Navigation Links
Amsterdam Molecular Therapeutics Reports Full Year Results 2007
Date:2/19/2008

Purchases of intangible fixed assets (357) (1,400)

Interest received 1,406 14

Net cash used in investing activities (296) (1,773)

Cash flow from financing activities

Proceeds from issuance of loans - 1,700

Redemption of loans (1,613) (1,700)

Capital contribution shareholders 51,361 -

Proceeds from issuance of preference - 21,821

shares

Net cash generated from financing 49,748 21,821

activities

Net (decrease)/ increase in cash,

cash equivalents

and bank overdrafts 37,272 13,537

Cash, cash equivalents and bank

overdrafts

In the beginning of the year 14,058 521

Cash, cash equivalents at the end of 51,330 14,058

the year


'/>"/>
SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Amsterdam Molecular Therapeutics to Appoint Philippe van Holle (Celgene) to Supervisory Board
2. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
3. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
4. Molecular Diagnostics Leader AdvanDx Taps Former Dako Executive Vice President to Lead Global Sales and Marketing Expansion
5. Acrongenomics on Track to Acquire Molecular Vision
6. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
7. Acrongenomics Acquires Equity Stake in Molecular Vision
8. The Dark Report and Siemens Introduce the Worlds First Integrated Molecular Summit
9. The Center for Molecular Medicine Doubles Lab Staff, Expands Lab Space by 100 Percent
10. Peakdale Molecular Announces GBP 1 Million Funding to Support Expansion and Growth
11. Center for Molecular Medicine Selected to Provide DNA Analysis for Childrens Oncology Group Leukemia Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... San Diego, Calif. (PRWEB) June 02, 2015 ... developer of build-to-order, independent blade-based and rackmount computing ... centers, today announced the launch of its high ... offering, the Cirrascale Slipstreamâ„¢ RM1622D . The ... Xeon® processor E3-1200 v4 product family with Intel® ...
(Date:6/2/2015)... 2015   BioClinica ® , Inc., a ... that David Peters , an accomplished senior finance ... and Chief Financial Officer (CFO) and will be joining ... more than 25 years of financial and accounting experience ... and deep knowledge in all areas of finance, accounting ...
(Date:6/2/2015)... , June 2, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: ... China,s leading provider of cord blood ... storage services, today announced that the Special Committee of the ... Houlihan Lokey ( China ) Limited as ... Hamilton LLP as its United States ...
(Date:6/2/2015)... GLASGOW, Scotland , June 2, 2015 /PRNewswire/ ... of addressing the global antibiotic resistance problem  ... truly novel class of anti-infectives, to address the ... that it has developed a stable intravenous (IV) ... susceptible and resistant Gram-positive hospital-acquired infections.  The ...
Breaking Biology Technology:Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 2Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 3BioClinica Names David Peters New Chief Financial Officer 2China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 2China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 3MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 2MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 3
... STATION, Texas, Aug. 26 Energy industry executives joined ... take a firsthand look at energy grasses and research ... forefront of renewable power and transportation fuels. ... provides a unique opportunity for industry leaders who may ...
... State Department of Health has licensed Genelex Corporation,s DNA Drug ... issued Clinical Laboratory Permit is for DNA testing of three ... of the most commonly prescribed medicines. Research shows the majority ... coding for these enzymes, greatly increasing their risk of treatment ...
... study from researchers in Canada and Sweden has shown that ... and improve vision in humans. The results, from an early ... August 25th, 2010 issue of Science Translational Medicine . ... to show that an artificially fabricated cornea can integrate with ...
Cached Biology Technology:Energy Grasses Take Center Stage at Ceres Field Day 2New York State Licenses Personalized Prescribing DNA Tests 2Seeing the world with new eyes: Biosynthetic corneas restore vision in humans 2
(Date:5/19/2015)... May 19, 2015  Technology is rapidly advancing, outpacing ... in the cloud. Passwords and their management are soon ... and standards-based specifications such as those developed by the ... of passwords presents for BYOD, COPE, IoT, and mobile ... identity protocol. In response to the ...
(Date:5/18/2015)... GOTHENBURG, Sweden , May 18, 2015 ... touch fingerprint sensors FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from ... place from June until and including Q3 2015 and the ... Asia . Communicated order values for 2015 hereby amount ... revenues for Q1 2015 of 140 MSEK and a number ...
(Date:5/14/2015)... 2015  Verificient Technologies, Inc., a technology ... remote proctoring, announced a new alliance partnership ... creator of the Canvas Learning Management System ... will benefit from the seamless integration of ... a fully integrated multifactor biometrics behavioral application, ...
Breaking Biology News(10 mins):HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2
... pneumococci ?the bugs targeted by vaccines recently announced by ... led by scientists from the Wellcome Trust Sanger Institute. ... targets of the vaccine that will help monitor the ... Pneumococci (formal name Streptococcus pneumoniae) are widespread, causing non-invasive ...
... and agriculture has destroyed 17 percent of the native ... , A new study published by Conservation International sounds ... the Pantanal. Continued deforestation at the current rate would ... in 45 years, according to CI researchers in Brazil. ...
... When it comes to gaining fat, insects and mammals may ... 2006, Cell Metabolism. The study finds that the so-called hedgehog ... the fates of many cell types--might also play an important ... findings are the first to show a conserved effect of ...
Cached Biology News:Outsmarting the smartie bug 2Outsmarting the smartie bug 3Report shows deforestation threatens Brazil's Pantanal 2Insects and mammals share common fat-building pathway, study suggests 2
... to Opsin 1 ( Abpromise for all ... peptide: YEDSTHASIFTYT, corresponding to amino acids 14/26 of ... corresponding to amino acids 18/30 of tiger red ... immunogen. Entrez Gene ID: ...
... The 200RT rotary tables offer precision ... is mount compatible with Parkers linear positioners ... height in multi-axis configurations., , Preloaded, ... rotation , Dual race preloaded angular contact ...
Anti-Mouse Macrophages (Metallophillic), Purified (Clone MOMA-1) (rat IgG2a)...
Human Osteocalcin (1-22) mature form. Also reacts with Osteocalcin (1-44) and Osteocalcin (1-49). No reactivity with Bone sialoprotein....
Biology Products: